Yelin Lapidot Holdings Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Yelin Lapidot Holdings Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.9M	Sell	352,579 -2,125	-0.6%	-$70.8K	2.26%	12
2026 Q1	$10.7M	Sell	354,704 -40,800	-10%	-$1.31M	2.23%	13
2025 Q4	$12.3M	Hold	395,504	–	–	2.47%	11
2025 Q3	$7.99M	Hold	395,504	–	–	1.68%	16
2025 Q2	$6.63M	Hold	395,504	–	–	1.21%	23
2025 Q1	$6.08M	Hold	395,504	–	–	1.17%	23
2024 Q4	$8.72M	Sell	395,504 -126,440	-24%	-$2.3M	1.52%	18
2024 Q3	$9.41M	Sell	521,944 -18,260	-3%	-$320K	1.55%	19
2024 Q2	$8.78M	Hold	540,204	–	–	1.55%	18
2024 Q1	$7.62M	Hold	540,204	–	–	1.57%	20
2023 Q4	$5.64M	Hold	540,204	–	–	1.36%	19
2023 Q3	$5.52M	Buy	+540,204	New	+$5.03M	1.36%	21

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Yelin Lapidot Holdings Management's TEVA Position: Q2 2026 in Review

Yelin Lapidot Holdings Management reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 0.6% in Q2 2026, selling an estimated $70.8K and leaving 352,579 shares worth $11.9M. The position accounts for 2.26% of the portfolio, ranked #12.

Yelin Lapidot Holdings Management first reported a position in TEVA in Q3 2023 and has held it in 12 quarters since. The position peaked at $12.3M in Q4 2025. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Yelin Lapidot Holdings Management held 352,579 shares of Teva Pharmaceutical Industries Limited worth $11.9M as of Q2 2026.
Yelin Lapidot Holdings Management sold 2,125 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $70.8K.
Teva Pharmaceutical Industries Limited made up 2.26% of Yelin Lapidot Holdings Management's portfolio in Q2 2026, its #12 holding.
Yelin Lapidot Holdings Management first reported a position in Teva Pharmaceutical Industries Limited in Q3 2023 and has held it in 12 quarters since.
Yelin Lapidot Holdings Management's Teva Pharmaceutical Industries Limited position peaked at $12.3M in Q4 2025.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Yelin Lapidot Holdings Management's 13F filing for Q2 2026, filed 3 Aug 2026.